C14-4

• CAT Number: I041193
• CAS Number: 2639634-80-1
• Molecular Formula: C84H173N5O7
• Molecular Weight: 1365.30
• Purity: ≥95%
• Synonyms: 1-[2-[2-[bis(2-hydroxytetradecyl)amino]ethoxy]ethyl-[2-[4-[2-[2-[bis(2-hydroxytetradecyl)amino]ethoxy]ethyl]piperazin-1-yl]ethyl]amino]tetradecan-2-ol
• InChI: InChI=1S/C84H173N5O7/c1-6-11-16-21-26-31-36-41-46-51-56-80(90)75-87(68-72-96-74-70-89(78-83(93)59-54-49-44-39-34-29-24-19-14-9-4)79-84(94)60-55-50-45-40-35-30-25-20-15-10-5)66-65-85-61-63-86(64-62-85)67-71-95-73-69-88(76-81(91)57-52-47-42-37-32-27-22-17-12-7-2)77-82(92)58-53-48-43-38-33-28-23-18-13-8-3/h80-84,90-94H,6-79H2,1-5H3
• InChIKey: OQALBVGFAKJDAR-UHFFFAOYSA-N
• SMILES: CCCCCCCCCCCCC(CN(CCN1CCN(CC1)CCOCCN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)CCOCCN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)O

C14-4（Cat No.:I041193）is an experimental compound being developed for its potential use in cancer therapy. It is designed to target and inhibit specific enzymes involved in tumor cell growth and survival, particularly in cancers that exhibit resistance to standard treatments. By disrupting key molecular pathways, C14-4 aims to reduce tumor proliferation, induce apoptosis, and overcome chemoresistance. Preclinical studies have shown promising results, and ongoing clinical trials are focused on assessing its safety, efficacy, and potential as a novel therapeutic agent for treating various solid tumors and hematologic malignancies.